Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 30, 2015
Pharmacy Choice - News - Drug Delivery Systems - July 30, 2015

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 25     Go To Page:

7/30/15 - Research and Markets Adds Report: Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 [Manufacturing Close - Up]
Research and Markets has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type, by Raw Material, by Drug Delivery Type by Region- Forecasts to 2020" report to its offerings. In a release, Research and Markets noted that report highlights include:. The global pharmaceutical packaging market demand, by value is estimated to
7/30/15 - Research and Markets Adds Report: Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 [Professional Services Close - Up]
Research and Markets has added the "Pharmaceutical Packaging Market by Packaging Type, Raw Material& Drug Delivery Type- Forecasts to 2020" report to its offerings. In a release, Research and Markets noted that report highlights include:. The global pharmaceutical packaging market demand, by value is estimated to reach above $80 Billion by 2020.
7/29/15 - Ethicon Endo-Surgery Assigned Patent for Drug Delivery System with Open Architectural Framework
ALEXANDRIA, Va., July 29 Ethicon Endo-Surgery, Cincinnati, has been assigned a patent developed by five co-inventors for a "drug delivery system with open architectural framework." The co-inventors are Paul J. Niklewski, Cincinnati, James F. Martin, Lebanon, Ohio, David Q. Feng, Mason, Ohio, Todd J. Mack, Loveland, Ohio, and Donn C. Mueller, Maso
7/29/15 - Heron Therapeutics Commences 2nd Phase 2 Clinical Trial of HTX-011 for the Treatment of Post-Operative Pain [Professional Services Close - Up]
Heron Therapeutics reported that it has initiated a second Phase 2 clinical trial of HTX-011. HTX-011, which utilizes Heron's proprietary Biochronomer drug delivery technology, is a long-acting formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam for the prevention of post-operative pain.
7/29/15 - Investigators at Budapest University of Technology and Economics Report Findings in Drug Delivery Systems [Interactions in aromatic probe molecule...
Investigators at Budapest University of Technology and Economics Report Findings in Drug Delivery Systems. According to news reporting from Budapest, Hungary, by NewsRx journalists, research stated, "Small aromatic molecules are known to interact with poly based hydrogels, one of the most frequently employed polymers in temperature induced drug del
7/29/15 - New Findings on Drug Delivery Systems from University of Cairo Summarized (Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug...
New Findings on Drug Delivery Systems from University of Cairo Summarized. By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on Drugs and Therapies. According to news reporting originating in Giza, Egypt, by NewsRx journalists, research stated, "Treatment of approximately 50% of human cancers includes the use o
7/29/15 - New Findings on Drug Delivery Systems Reported by G.D. Zhao et al (Development of novel composite antioxidant multiple lipid particles from...
New Findings on Drug Delivery Systems Reported by G.D. Zhao et al. By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on Drugs and Therapies. According to news originating from Suzhou, People's Republic of China, by NewsRx correspondents, research stated, "A novel drug delivery system, multiple solid particles,
7/29/15 - Patent Issued for Drug Delivery Device
By a News Reporter-Staff News Editor at Journal of Engineering According to news reporting originating from Alexandria, Virginia, by VerticalNews journalists, a patent by the inventors Harms, Michael; Raab, Steffen; Dasbach, Uwe; Stauder, Udo, filed on March 31, 2010, was published online on July 14, 2015. The assignee for this patent, patent num
7/29/15 - Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry
Research and Markets has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type, by Raw Material, by Drug Delivery Type by Region- Forecasts to 2020" report to their offering. The global pharmaceutical packaging market demand, by value is estimated to reach above $80 Billion by 2020. Increasing overall packaging cost along
7/29/15 - Reports from School of Pharmacy Provide New Insights into Drug Delivery Systems (Electrospun medicated shellac nanofibers for colon-targeted drug...
Reports from School of Pharmacy Provide New Insights into Drug Delivery Systems. By a News Reporter-Staff News Editor at Biotech Week Fresh data on Drugs and Therapies are presented in a new report. Our news journalists obtained a quote from the research from the School of Pharmacy, "The presence of the shell fluid was required to prevent frequen
7/29/15 - Research Conducted by G. Vizseralek and Co-Authors Has Provided New Information about Transdermal Delivery (Permeability test for transdermal and...
Research Conducted by G. Vizseralek and Co-Authors Has Provided New Information about Transdermal Delivery. By a News Reporter-Staff News Editor at Biotech Week Current study results on Drugs and Therapies have been published. According to news reporting originating from Sopron, Hungary, by NewsRx correspondents, research stated, "Using the skin
7/29/15 - Studies from Hoshi University Have Provided New Information about Drug Delivery Systems [Development of liposomal nanoconstructs targeting P-selectin...
By a News Reporter-Staff News Editor at Biotech Week A new study on Drugs and Therapies is now available. According to news originating from Tokyo, Japan, by NewsRx correspondents, research stated, "NMSO3, a sulfated derivative of sialic acid, is a specific inhibitor for P-selectin- mediated cell adhesion. Our news journalists obtained a quote fr
7/29/15 - Study Findings from University of Montpellier Broaden Understanding of Drug Delivery Systems (After soft tissues, bone, drug delivery and packaging,...
Study Findings from University of Montpellier Broaden Understanding of Drug Delivery Systems. By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on Drugs and Therapies. According to news originating from Montpellier, France, by NewsRx editors, the research stated, "Natural polymeric materials have been used for.
7/29/15 - Study Results from B. Zorec and Colleagues Broaden Understanding of Transdermal Delivery (Ultrasound and electric pulses for transdermal drug...
Study Results from B. Zorec and Colleagues Broaden Understanding of Transdermal Delivery. By a News Reporter-Staff News Editor at Biotech Week Fresh data on Drugs and Therapies are presented in a new report. For more information on this research see: Ultrasound and electric pulses for transdermal drug delivery enhancement: Ex vivo assessment of m
7/28/15 - European Injectable Drug Delivery Market Worth $207.3 Billion by 2020
According to a new market research report " European Injectable Drug Delivery Market By Type, Therapeutic, Usage Pattern, Administration, End User- Forecast to 2020", published by MarketsandMarkets, the European Injectable Drug Delivery Market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2
7/28/15 - Gerresheimer Agrees To Buy Nemera Development For $725 Mln
DUESSELDORF- German drug delivery devices maker Gerresheimer AG said it has reached an agreement with Nemera Development S.A. to acquire 100 percent of the share capital of Centor US Holding Inc. The total consideration amounts to $725 million on a cash-free and debt-free basis. Gerresheimer said it would further extend its primary pharmaceutical..
7/28/15 - Heron Therapeutics Commences 2nd Phase 2 Clinical Trial of HTX-011 for the Treatment of Post-Operative Pain [Health & Beauty Close - Up]
Heron Therapeutics reported that it has initiated a second Phase 2 clinical trial of HTX-011. HTX-011, which utilizes Heron's proprietary Biochronomer drug delivery technology, is a long-acting formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam for the prevention of post-operative pain.
7/28/15 - Reports Outline Drug Delivery Systems Study Results from East China University of Science and Technology (A functional drug delivery platform for...
Reports Outline Drug Delivery Systems Study Results from East China University of Science and Technology. According to news reporting originating from Shanghai, People's Republic of China, by NewsRx correspondents, research stated, "Functional polymeric micelles play an important role in the efficient delivery of therapeutic drugs into tumours.
7/27/15 - MonoSol Rx Announces Initiation of Phase 2a Trial for Oral Insulin Film
MonoSol Rx, the developer of PharmFilm drug delivery technology, with its partner Midatech Pharma, announced today that it has initiated a Phase 2 a study for Midaform Insulin PharmFilm , MSL- 001, with the dosing of its first patient. The study is being conducted in Perth, Australia, with a total of 12 patients, male and female, aged 18 to
7/27/15 - Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020
Dublin- Research and Markets has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type, by Raw Material, by Drug Delivery Type by Region- Forecasts to 2020" report to their offering. The global pharmaceutical packaging market demand, by value is estimated to reach above $80 Billion by 2020. The pharmaceutical packaging ma
7/27/15 - Research and Markets: Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020
Research and Markets has announced the addition of the "Pharmaceutical Packaging Market by Packaging Type, by Raw Material, by Drug Delivery Type by Region- Forecasts to 2020" report to their offering. The global pharmaceutical packaging market demand, by value is estimated to reach above $80 Billion by 2020. The pharmaceutical packaging market is
7/26/15 - Purchase with the delivery of cancer drugs and generic drugs for hospital pharmacies holy cross cancer center in kielce. [TendersInfo (India)]
Contract notice: Purchase with the delivery of cancer drugs and generic drugs for hospital pharmacies holy cross cancer center in kielce. Time-limit for receipt of tenders or requests to participate: 02/09/2015- 1000 Conditions for opening tenders Date: 02.09. 2015- 10:30 Language in which tenders or requests to participate may be drawn up: Polish.
7/26/15 - United Kingdom : CAPSUGEL expands SCOTTISH plant [TendersInfo (India)]
Capsule maker and drug formulation expert Capsugel has been strengthening its production capacities across the world and will now focus on a plant in Scotland that it picked up in 2013.. The New Jersey- based firm said the facility in Edinburgh, which it received in 2013 as part of its acquisition of Encap Drug Delivery, is already one of the leadi
7/24/15 - Researchers from Sichuan University Discuss Findings in Taxoids (Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid...
By a News Reporter-Staff News Editor at Drug Week Investigators discuss new findings in Taxoids. According to news originating from Chengdu, People's Republic of China, by NewsRx correspondents, research stated, "To develop a tumor-targeted drug delivery system based on solid lipid nanoparticles conjugated with the enzymatically cleavable polyeth
7/23/15 - Heron Therapeutics Initiates Second Phase 2 Clinical Trial of HTX-011 for the Treatment of Post-Operative Pain
Heron Therapeutics, Inc., a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, today announced that it has initiated a second Phase 2 clinical trial of HTX-011. HTX-011, which utilizes Heron s proprietary Biochronomer drug delivery technology, is a lon
Articles(s): 1 - 25 of 25     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415